AS24 - Pulmonary Manifestations of Systemic Disease Abstract Publication

COMPARISON OF THE EFFICACY AND SAFETY OF CYCLOPHOSPHAMIDE (СP) AND RITUXIMAB (RTM) IN PATIENTS WITH SYSTEMIC SCLEROSIS(SSC) WITH INTERSTITIAL LUNG DISEASE (ILD).

Session Name
AS24 - Pulmonary Manifestations of Systemic Disease
Presentation Type
Abstract Submission

Previous ePoster
RELATIONSHIP BETWEEN LUNG FUNCITON TEST AND DIGITAL ULCERS (DUS) IN PATIONTS WITH SYSTEMIC SCLEROSIS (SSC) OVER A FIVE-YEAR PERIOD.

Next ePosters
COMPARISON OF THE RITUXIMAB(RTM) EFFICACY IN MONOTHERAPY REGIMEN AND IN COMBINATION WITH IMMUNOSUPPRESSANTS IN SYSTEMIC SCLEROSIS (SSC) WITH INTERSTITIAL LUNG DISEASE (ILD)
ASSOCIATION OF PULMONARY FUNCTION TESTS WITH INFLAMMATORY MARKERS C-REACTIVE PROTEIN AND ERYTHROCYTE SEDIMENTATION RATE IN FOLLOW UP STUDY.
ILEOCOLIC INTUSSUSCEPTION: A RARE CASE REPORT OF MULTI-SYSTEMIC SARCOIDOSIS
THE CASE OF LYMPHOMATOID GRANULEMATOSIS WITH PULMONARY AND SKIN INVOLVEMENT IN A FEMALE PATIENT
END TIDAL CO2 LEVELS IN HEALTHY ADULTS WHILE BREATHING THROUGH A FULL-FACE SNORKEL MASK
MECHANICAL VENTILATION GUIDED BY TRANSPULMONARY AND AIRWAY DRIVING PRESSURES IN THE SETTING OF INTRAABDOMINAL HYPERTENSION
HICCUPS ALWAYS CEASE WHEN EXPOSED TO ACUTE HYPERCAPNIA
DRUG-DRUG INTERACTION STUDY BETWEEN ZAMICASTAT AND BOSENTAN IN HEALTHY SUBJECTS
PULMONARY REHABILITATION IN RESOURCE SCARCE SETTINGS: A ONE YEAR EXPERIENCE
FROM HEALTH RELATED QUALITY OF LIFE TO FUNCTIONAL AEROBIC CAPACITY: THE BENEFITS OF PULMONARY REHABILITATION IN COLOMBIAN PATIENTS WITH SEQUELAE OF PULMONARY TUBERCULOSIS